1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Hepatitis E virus RNA‐dependent RNA polymerase is involved in RNA replication and infectious particle production

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background and Aims

          Hepatitis E virus (HEV) is one of the most common causes of acute hepatitis worldwide. Its positive‐strand RNA genome encodes three open reading frames (ORF). ORF1 is translated into a large protein composed of multiple domains and is known as the viral replicase. The RNA‐dependent RNA polymerase (RDRP) domain is responsible for the synthesis of viral RNA.

          Approach and Results

          Here, we identified a highly conserved α‐helix located in the RDRP thumb subdomain. Nuclear magnetic resonance demonstrated an amphipathic α‐helix extending from amino acids 1628 to 1644 of the ORF1 protein. Functional analyses revealed a dual role of this helix in HEV RNA replication and virus production, including assembly and release. Mutations on the hydrophobic side of the amphipathic α‐helix impaired RNA replication and resulted in the selection of a second‐site compensatory change in the RDRP palm subdomain. Other mutations enhanced RNA replication but impaired virus assembly and/or release.

          Conclusions

          Structure‐function analyses identified a conserved amphipathic α‐helix in the thumb subdomain of the HEV RDRP with a dual role in viral RNA replication and infectious particle production. This study provides structural insights into a key segment of the ORF1 protein and describes the successful use of reverse genetics in HEV, revealing functional interactions between the RDRP thumb and palm subdomains. On a broader scale, it demonstrates that the HEV replicase, similar to those of other positive‐strand RNA viruses, is also involved in virus production.

          Related collections

          Most cited references35

          • Record: found
          • Abstract: found
          • Article: not found

          HELIQUEST: a web server to screen sequences with specific alpha-helical properties.

          HELIQUEST calculates the physicochemical properties and amino acid composition of an alpha-helix and screens databank to identify protein segments possessing similar features. This server is also dedicated to mutating helices manually or automatically by genetic algorithm to design analogues of defined features. http://heliquest.ipmc.cnrs.fr.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Efficient initiation of HCV RNA replication in cell culture.

            Hepatitis C virus (HCV) infection is a global health problem affecting an estimated 170 million individuals worldwide. We report the identification of multiple independent adaptive mutations that cluster in the HCV nonstructural protein NS5A and confer increased replicative ability in vitro. Among these adaptive mutations were a single amino acid substitution that allowed HCV RNA replication in 10% of transfected hepatoma cells and a deletion of 47 amino acids encompassing the interferon (IFN) sensitivity determining region (ISDR). Independent of the ISDR, IFN-alpha rapidly inhibited HCV RNA replication in vitro. This work establishes a robust, cell-based system for genetic and functional analyses of HCV replication.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

              New drugs for hepatitis C The development of direct-acting antiviral agents to treat chronic hepatitis C virus (HCV) infection, much needed clinically, has focused largely on inhibitors of two viral enzymes, the protease NS3 and NS5B, an RNA-dependent RNA polymerase essential for HCV replication. BMS-790052, identified using chemical genetics as a powerful specific HCV inhibitor, is a small-molecule inhibitor of a third viral molecule that has no known enzyme activity, the non-structural protein 5A (NS5A). A research team from Bristol-Myers Squibb this week reports on the discovery and virological profile of BMS-790052 and discloses clinical trial observations with this compound in normal healthy volunteers and HCV-infected subjects. These results establish proof-of-concept for HCV NS5A inhibition as a clinically relevant mechanism. In vitro data point to synergistic interactions with known HCV inhibitors, suggesting that cocktails of antiviral agents may be a viable therapeutic approach. Supplementary information The online version of this article (doi:10.1038/nature08960) contains supplementary material, which is available to authorized users.
                Bookmark

                Author and article information

                Contributors
                Darius.Moradpour@chuv.ch
                Jerome.Gouttenoire@chuv.ch
                Journal
                Hepatology
                Hepatology
                10.1002/(ISSN)1527-3350
                HEP
                Hepatology (Baltimore, Md.)
                John Wiley and Sons Inc. (Hoboken )
                0270-9139
                1527-3350
                08 December 2021
                January 2022
                : 75
                : 1 ( doiID: 10.1002/hep.v75.1 )
                : 170-181
                Affiliations
                [ 1 ] Division of Gastroenterology and Hepatology Lausanne University Hospital and University of Lausanne Lausanne Switzerland
                [ 2 ] UMR1167 University of Lille INSERM Lille University Hospital Institut Pasteur de Lille Lille France
                [ 3 ] CNRS, ERL9002 ‐ Integrative Structural Biology Lille France
                Author notes
                [*] [* ] Correspondence

                Darius Moradpour and Jérôme Gouttenoire, Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 48, CH‐1011 Lausanne, Switzerland.

                Email: Darius.Moradpour@ 123456chuv.ch and Jerome.Gouttenoire@ 123456chuv.ch

                Author information
                https://orcid.org/0000-0003-1977-6792
                https://orcid.org/0000-0002-7715-1494
                Article
                HEP32100
                10.1002/hep.32100
                9300124
                34387882
                d4f9f82f-0006-4daa-8ab8-e3ee9fa3f493
                © 2021 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 09 July 2021
                : 06 May 2021
                : 31 July 2021
                Page count
                Figures: 6, Tables: 0, Pages: 12, Words: 6898
                Funding
                Funded by: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung , doi 10.13039/501100001711;
                Award ID: 31003A‐179424
                Award ID: CRSK‐3_190706
                Funded by: Agence Nationale de Recherches sur le Sida et les Hepatites Virales
                Award ID: ECTZ101316
                Funded by: Novartis Foundation , doi 10.13039/100008273;
                Award ID: 18C140
                Categories
                Original Article
                Original Articles
                Viral Hepatitis
                Custom metadata
                2.0
                January 2022
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.7 mode:remove_FC converted:20.07.2022

                Gastroenterology & Hepatology
                Gastroenterology & Hepatology

                Comments

                Comment on this article